FX-as-a-Service
Posted by Colin Lambert. Last updated: April 22, 2025
By Aled Basey, Head of HausFX & FX Execution Advisory, UK, Deutsche Bank
- What is it?
FX-as-a-Service will mean different things to different people, as automation solutions are user and institutionally specific. To cater for this, it requires the technology to be able to manage each and every stage of the FX trade lifecycle, from calculation through to settlement, delivered to clients in a transparent and operationally robust way.
At Deutsche Bank, the workflow automation technology suite is called HausFX. Its modular design allows clients to target the specific workflows they want to enhance with HausFX solutions.
2. Why now?
There are a combination of ‘push’ and ‘pull’ factors for the FX market as a whole, as to why this is the right time.
In terms of ‘push’ the buyside management fee compression drives the need to improve efficiency and optimise their existing workflows. Couple that with increased regulatory headwinds and the need for operational resilience. Then there is the realisation that for the majority of FX participants, their FX is not being traded for alpha. For those instances where they are taking an active view, our execution advisory team has been set up to help optimise their execution tools and decisions. However, FX for a non-FX PM is largely a by-product, almost a referee within a football match – the best performance is not knowing they are there at all. There have been a few articles recently discussing market structure, the ever-increasing number of venues resulting in increased fragmentation, driving up the cost of running an FX business.1
A key ‘pull’ factor is how electronic the FX market is, which provides the foundations needed for clients to leverage their data and the electronic execution network to automate and optimise their executions in a smart way. Utilising technology to drive efficiency becomes the obvious choice. By inserting tech-first solutions, the ingredients are right for rapid and sustained scale, removing the historic barriers to progress from incumbent solutions. Another pull factor is certainly the speed at which restricted markets are evolving, improving market access and increasing transparency and supporting efficiency for the market in general.
3. Who – buyside/sellside
Different client types, have different specific challenges, meaning no single solution solves all problems. What is required is a technology suite that is both flexible and scalable, such that it can fit within the client’s existing workflow to ensure no additional point of failure. We’re very fortunate to have that available to us within HausFX.
On the sell-side, regional champions are looking to offer best-in-class solutions to their clients but face the same regulatory burdens as larger peers. Margins continue to erode, increasing the focus on cost optimisation by either: reduce trading costs or reduce operational and/or technology costs. HausFX looks to partner with clients to address their specific challenges, helping them achieve those goals. This results in reframing their relationship with Deutsche Bank from pure Liquidity Provider to Technology Partner. If there is an overarching theme, it would be that clients are looking to double down on their own areas of strength but then look to partner for scale in areas which are extremely competitive.
On the buy-side, there are a plethora of different potential use cases. Anything manual, repetitive and non-alpha generative is typically ripe for automation and the benefits of the operational risk reduction that brings. It can be as easy as a workflow for security-linked FX, all the way through to a sophisticated hedging programme. It sounds obvious, but the key to selling any technology is to listen to clients, solve for their needs and keep iterating the product.
The return of the higher volatility environment has certainly sharpened focus on any legacy workflows clients may have in place, for example we’ve recently heard from equity asset managers who have historically opted to hedge their FX daily to attempt to maximise their netting, only to now see their performance eroded by the delay to the execution time – prompting the desire for a new technology solution. That’s really where our HausFX product suite can be deployed, its dynamic automation is well suited to tailor hedging methodology depending on the environment – so those equity funds could have switched onto different hedging profile, to avoid any long delays to execution.
4. Considerations
For any clients reviewing their FX business, across buy or sell side, we’d encourage them to get in touch. We have been through many different scenarios with different client types, that it makes sense to put heads together and collaborate – of course, if we can help solve a problem then great, but if nothing else we look to leave all our clients and prospects with the ability to make more informed decisions on what the right execution process should look like for their FX business.
The_Brilliant_World_of_FX_-_A_Primer.PDF
Disclaimer
This document is intended for the personal use of the recipient for discussion purposes only and does not create any legally binding obligations on the part of Deutsche Bank AG and/or its affiliates (“DB”). Without limitation, this document does not constitute an offer, an invitation to offer or a recommendation to enter into any transaction. When making an investment decision, you should rely solely on any specific final documentation relating to a transaction and not the summary contained herein. DB is not acting as your legal, financial, tax or accounting adviser or in any other fiduciary capacity with respect to any proposed transaction mentioned herein. This document does not constitute the provision of investment advice and is not intended to do so, but is intended to be general information. Any product(s) or proposed transaction(s) mentioned herein may not be appropriate for all investors and before entering into any transaction you should take steps to ensure that you fully understand the transaction and have made an independent assessment of the appropriateness of the transaction in the light of your own objectives, needs and circumstances, including the possible risks and benefits of entering into such transaction. For general information regarding the nature and risks of the proposed transaction and types of financial instruments please go to https://www.db.com/company/en/legal-resources.htm under the heading “Risk Disclosures”. You should also consider seeking advice from your own advisers in making any assessment on the basis of this document. If you decide to enter into a transaction with DB, you do so in reliance on your own judgment. The information contained in this document is based on material we believe to be reliable as of the date hereof; however, we do not represent that it is accurate, current, complete, or error free. Assumptions, estimates and opinions expressed constitute the Author’s judgment as of the date of the Message and are subject to change without notice. Any projections are based on a number of assumptions as to market conditions and there can be no guarantee that any projected results will be achieved. Past performance does not guarantee or predict future results. DB has no obligation to update, modify or amend this report or to otherwise notify a recipient thereof if any opinion, forecast or estimate set forth herein changes or subsequently becomes inaccurate.
This material was prepared by a Sales or Trading function within DB, and was not produced, reviewed or edited by the Research Department. Any opinions expressed herein may differ from the opinions expressed by other DB departments including the Research Department. Sales and Trading functions are subject to additional potential conflicts of interest which the Research Department does not face, so this material should not necessarily be considered objective or unbiased. Sales and Trading personnel are compensated in part based on the volume of transactions effected by them. Deutsche Bank may engage in transactions in a manner inconsistent with the views discussed herein. Deutsche Bank trades or may trade as principal in the instruments (or related derivatives), and may have proprietary positions in the instruments (or related derivatives) discussed herein. Deutsche Bank may make a market in the instruments (or related derivatives) discussed therein; and the Author may know the nature of such trading positions and strategies. DB seeks to transact business on an arm’s length basis with sophisticated investors capable of independently evaluating the merits and risks of each transaction, with investors who make their own decision regarding those transactions. Certain transactions or securities mentioned herein, including derivative products, give rise to substantial risk, including currency and volatility risk, and are not suitable for all investors. This material is intended for institutional customers or accredited investors only and may be furnished for informational purposes only. If you believe you have received material which you deem not to be an acceptable minor non-monetary benefit (“AMNMBs”), please contact the sender to discuss appropriate arrangements or payment options.
DB SPECIFICALLY DISCLAIMS ALL LIABILITY FOR ANY DIRECT, INDIRECT, CONSEQUENTIAL OR OTHER LOSSES OR DAMAGES INCLUDING, BUT NOT LIMITED TO, LOSS OF PROFITS INCURRED BY YOU OR ANY THIRD PARTY THAT MAY ARISE FROM ANY RELIANCE ON THIS DOCUMENT OR FOR THE RELIABILITY, ACCURACY, COMPLETENESS OR TIMELINESS THEREOF.
Deutsche Bank AG is authorized under German Banking Law (competent authority: European Central Bank) and, in the United Kingdom, by the Prudential Regulation Authority. It is subject to supervision by the European Central Bank and by BaFin, Germany’s Federal Financial Supervisory Authority, and is subject to limited regulation in the United Kingdom by the Prudential Regulation Authority and Financial Conduct Authority. The distribution of this document and availability of these products and services in certain jurisdictions may be restricted by law. This report may not be reproduced, distributed or published by any person for any purpose in whole, or in part, without Deutsche Bank’s prior written consent. Unless governing law provides otherwise, all transactions should be executed through the Deutsche Bank entity in the investor’s home jurisdiction.
In the US this document is approved and or distributed by Deutsche Bank Securities Inc., a member of the NYSE, FINRA, NFA and SIPC. This material is for our clients’ informational purposes and is a general solicitation of derivatives business for the purposes of, and to the extent it is subject to, §§ 1.71 and 23.605 of the U.S. Commodity Exchange Act. This material should not be construed as an offer to sell or the solicitation of an offer to buy any security in any jurisdiction where such an offer or solicitation would be illegal. We are not soliciting any specific action based on this material. It does not constitute a recommendation or take into account the particular investment objectives, financial condition or needs of individual clients. This material, and the information contained therein, does not constitute the provision of investment advice. Deutsche Bank is not acting as your municipal advisor, swap advisor, financial advisor or in any other advisory, agency or fiduciary capacity with respect to any transaction with you (whether or not Deutsche Bank has provided or is currently providing other services to you on related or other matters) unless expressly agreed by Deutsche Bank in writing.
In the United Kingdom this material is approved and/or communicated by Deutsche Bank AG London, a member of the London Stock Exchange. In Hong Kong, this document is distributed by Deutsche Securities Asia Limited (“DSAL”) and Deutsche Bank AG (“DBAG”). DSAL is an exchange participant of The Stock Exchange of Hong Kong Limited and a licensed corporation with the Securities and Futures Commission. Deutsche Bank AG is regulated by the Hong Kong Monetary Authority as a licensed bank. This document is intended for “Professional Investors” within the meaning of the Securities and Futures Ordinance (Cap. 571) and any rules made thereunder. In Singapore, this document is intended and provided exclusively for certain institutional and accredited investors as defined pursuant to section 4A of the Securities and Futures Act, Chapter 289 of Singapore (the “Institutional Investors”).